AVAC in the News
“HIV prevention science has reached a historic peak, but the infrastructure required to deliver that science is being dismantled.”
Results
showing 1-10 of 818
When Budgets are Tight, How Do We Do More with Less? [VIDEO]
"We actually need to start prioritizing differently and better and making sure we're not doing things that aren't adding value and delivering impact," said AVAC Executive Director Mitchell Warren, speaking with Devex at WHA79.
Source: Devex
The Trump Administration’s Long-Awaited Global Health Nomination
“I am relieved that this Administration finally nominated an Ambassador for Global Health Security and Diplomacy,” Mitchell Warren, executive director of AVAC, tells me. The timing matters, he says, given pressing global health threats, such as the ongoing Ebola outbreak, and the US’ commitment to scale up lenacapavir for HIV prevention.
Source: Devex
Did US Aid Cuts Break Precisely the Things We Need Most for the Lenacapavir Rollout?
“South Africa is home to the largest and most successful PrEP programme in the world, even though it has not delivered the impact we wanted,” says Mitchell Warren, Executive Director of AVAC. Warren’s point about the impact not being what we wanted, refers to the fact that, comparatively large as our PrEP programme is, uptake has been much lower than what was hoped.
Source: Spotlight
Accountability, Resistance, and Dissent in Public Health
President Trump’s fiscal year 2026 budget proposed a 50% cut in the CDC’s funding, slashing nearly five billion dollars. Chronic disease prevention funding was cut, along with US$12 billion for public health programs to states. Funding for disease surveillance and vaccines for children and uninsured adults were similarly targeted. Resistance has also come from litigation, filed by organizations such as Public Citizen, the American Public Health Association, the AIDS Vaccine Advocacy Coalition, and the Global Health Council. Outcomes have been mixed.
Source: Health and Human Rights
‘It’s Like We Just Dumped Them’
“The science of HIV prevention has reached a historic peak,” said Mitchell Warren of US-based health nonprofit AVAC. “But the infrastructure required to deliver that science is being systematically dismantled.”
Source: The Continent
Scientific Breakthroughs and Political Retreat Set the Stage for a Crucial Global Moment in the Fight Against HIV/AIDS
Ahead of the upcoming UN High-Level Meeting on HIV/AIDS, AVAC Executive Director Mitchell Warren talks about the scientific breakthroughs speeding progress toward ending HIV/AIDS as a public health threat—and why funding cuts and weakening political commitment are landing at the worst possible moment, just as those breakthroughs come within reach.
Source: Global Dispatch
The US Cut Billions in Health Aid for Africa. We Went There to See the Impact.
The closure of USAID shook the world, especially the USAID-dependent NGOs scrambling to close abruptly and figure out their future after the Trump administration shut down the federal agency committed to humanitarian aid.
Source: WUSA9
The Promise — and Pitfalls — of Lenacapavir
“There are many cruel ironies over these last 15 months, but I believe [lenacapavir] really represents the cruelest irony,” said Mitchell Warren, the executive director of global HIV prevention advocacy group AVAC.
Source: Devex
The HIV Prevention Jab Scientists Hoped for is Finally Here. Now Comes the Hard Part.
South Africa’s June launch can become more than a symbolic event. It can show what serious HIV prevention leadership looks like at a time when donor funding is shrinking and global uncertainty is growing.
Source: Bhekisisa
HIV Vaccine Awareness Day and NMAC’s New Factsheet
As the quest for an HIV vaccine continues, this day is also an opportunity to highlight how other vaccines are a critical component of HIV care.
Source: POZ
showing 1-10 of 818